<- Go Home

JW Lifescience Corporation

JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.

Market Cap

KRW 173.3B

Volume

57.9K

Cash and Equivalents

KRW 8.9B

EBITDA

KRW 52.0B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

KRW 72.9B

Profit Margin

28.84%

52 Week High

KRW 15.6K

52 Week Low

KRW 10.6K

Dividend

N/A

Price / Book Value

0.79

Price / Earnings

5.94

Price / Tangible Book Value

1.22

Enterprise Value

KRW 203.3B

Enterprise Value / EBITDA

3.91

Operating Income

KRW 33.4B

Return on Equity

13.98%

Return on Assets

6.53

Cash and Short Term Investments

KRW 12.2B

Debt

KRW 42.3B

Equity

KRW 218.7B

Revenue

KRW 252.7B

Unlevered FCF

KRW 24.7B

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches